FCS Advances Oncology Care Through Expert Collaboration and Innovative Exchange at Exclusive Event

Leading experts convene to share cutting-edge data, emerging treatment strategies and collaborative insights to advance personalized cancer care in community settings

Fort Myers, Fla., April 24, 2026 — Florida Cancer Specialists & Research Institute, LLC  is again partnering with Research to Practice® for the Fifth Annual National General Medical Oncology Summit in Orlando. The one-of-a-kind educational experience will provide insights from some of the leading experts in the field through a dynamic mix of presentations, engaging moderated panel discussions and Q&A sessions focused on significant new datasets, emerging treatment strategies and key interdisciplinary management considerations.

“This event is designed to address the specific needs of medical oncologists and frontline cancer care professionals,” said FCS President & Managing Physician Lucio N. Gordan, MD. “Featuring a distinguished faculty of clinical researchers and practicing experts, the program delivers cutting-edge data and actionable insights that support both clinical and operational decision-making. This integrated approach is critical to equipping providers with the tools they need to deliver highly personalized care and achieve the best possible outcomes for their patients.”

The following FCS medical oncologists and hematologists will moderate didactic presentations and discussions on a variety of oncology topics:

• Susmitha Apuri, MD – Chronic Lymphocytic Leukemia and HR-Positive Breast Cancer
• Mamta T. Choksi, MD – Colorectal Cancer and Gastroesophageal Cancer
• Uday Dandamudi, MD – HER2-Positive Breast Cancer and Prostate Cancer
• Maria Regina Flores, MD – EGFR Mutation-Positive Non-Small Cell Lung Cancer
• Gustavo Adolf Fonseca, MD, FACP, FCS director of research & clinical trials – Bladder Cancer and Targeted Acute Myeloid Leukemia
• Sunil Gandhi, MD, FACP – Ovarian Cancer and Targeted Therapies for Non-Small Cell Lung Cancer
• Maen Hussein, MD, FCS medical director of value-based care – Myelofibrosis and Systemic Mastocytosis
• Vikas Malhotra, MD – Pancreatic Cancer and Triple-Negative Breast Cancer (TNBC)
• Shachar Peles, MD, FCS director of cell therapy – Desmoid Tumors and Soft Tissue Sarcoma and Mastocytosis and Relapsed/Refractory Multiple Myeloma

Doug Flora, MD, renowned medical director of oncology services at St. Elizabeth Healthcare in Northern Kentucky, is the keynote speaker for an FCS-exclusive session a leading voice in the integration of AI in cancer care, and author of Rebooting Cancer Care: Can AI Make Care More Human Again.

Ryan Ciarrocchi, FCS chief executive officer, said, “This premier event continues to earn national recognition for driving meaningful collaboration and innovation that enhance oncology care and elevate the patient experience in community settings nationwide.”

FCS is hosting additional opportunities for FCS physicians and clinicians to share perspectives and network with colleagues and future oncologists throughout the course of the weekend.

FCS is hosting additional opportunities for FCS physicians and clinicians to share perspectives and network with colleagues and future oncologists throughout the course of the weekend.